Jaclyn Kovach, MD
Ophthalmology · Miami, FLNPI 1174530323
Payments from drug & device makers
Across 263 payments — averaging $2241.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$231K
- AstraZeneca$118K
- Regeneron Healthcare Solutions, Inc.$92K
- Astellas Pharma US Inc$48K
- Novartis$46K
- Regeneron$38K
- plus $17K from 10 others
Across 7 payments — averaging $132.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$929
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 88 | $231,057 |
| AstraZeneca | 5 | $118,442 |
| Regeneron Healthcare Solutions, Inc. | 63 | $91,803 |
| Astellas Pharma US Inc | 25 | $47,650 |
| Novartis | 31 | $45,597 |
| Regeneron | 17 | $38,189 |
| Genentech USA, Inc. | 15 | $9,656 |
| F. Hoffmann-la Roche AG | 3 | $4,502 |
| Ocular Therapeutix, Inc. | 2 | $2,111 |
| AbbVie(2 entities) | 6 | $201 |
| Amgen(2 entities) | 2 | $144 |
| Alimera Sciences, Inc. | 1 | $127 |
| Harrow Eye, LLC | 1 | $62 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $45 |
| Aerie Pharmaceuticals, Inc. | 1 | $32 |
| Alcon | 1 | $16 |
How this compares
$589,634 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Miami
- Guillermo AmescuaMiami$962K
- Felipe MedeirosMiami$935K
- Jennifer LohMiami$606K
- William TrattlerMiami$580K
- Wilfredo LaraMiami$526K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$351K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.